Abstract
To study the effects of antiglaucoma drugs on metabolism within the extracellular matrix (ECM) of the ocular surface, including corneal, conjunctival, and subconjunctival tissue. Several antiglaucoma drugs--including beta-blockers, alpha/beta-blockers, alpha1-blocker, alpha2-agonist, and prostaglandin derivative-were topically administrated to rat eyes daily for 2 weeks or were incubated with human corneal cells or human fibroblasts for 72 hours. Thereafter, expression and enzymatic activity of the matrix metalloproteinases (MMPs), a group of enzymes proteolyzing ECM and their inhibitors, called tissue inhibitors of metalloproteinase (TIMPs), were evaluated. Quantitative RT-PCR revealed significantly upregulated and downregulated expression of MMPs and TIMPs, respectively, in rat conjunctival and subconjunctival tissue on the administration of alpha/beta-blockers, alpha1-blocker, alpha2-agonist, and prostaglandin derivative, suggesting that these drugs may enhance ECM degradation. However, in contrast, beta-blocker administration caused reverse effects--that is, upregulation and downregulation of TIMPs and MMPs, respectively. Enzymatic activity of MMPs in rat conjunctival and subconjunctival tissue analyzed by biochemical assay...Continue Reading
Citations
Mar 26, 2011·Eye·M L SalvetatP Brusini
Feb 25, 2010·Journal of Glaucoma·Chiara BergonziGiovanni Staurenghi
Oct 31, 2008·The British Journal of Ophthalmology·N TeraiL E Pillunat
Nov 28, 2012·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·H Thieme, K K van der Velden
May 17, 2014·Current Eye Research·Antoine LabbéChristophe Baudouin
Apr 29, 2011·Experimental Eye Research·Stella Arthur, Louis B Cantor
May 29, 2007·Ophthalmology·Christophe BaudouinFrançoise Brignole-Baudouin
Jun 10, 2008·Acta Ophthalmologica·Christophe Baudouin
Mar 1, 2012·British Journal of Pharmacology·A Rietz, Jp Spiers
Aug 21, 2012·Acta Ophthalmologica·Elisabeth M MessmerAnselm Kampik
Oct 15, 2014·Acta Ophthalmologica·Minna Helin-ToiviainenHannu Uusitalo
Jan 16, 2015·Acta Ophthalmologica·Juha Välimäki, Hannu Uusitalo
May 29, 2015·BMC Ophthalmology·Samin HongGong Je Seong
May 11, 2016·The British Journal of Ophthalmology·Roman MedaIsabelle Brunette
Sep 28, 2017·Expert Opinion on Therapeutic Targets·Jeffrey O'CallaghanPete Humphries
Mar 8, 2019·Cutaneous and Ocular Toxicology·Emine SenUfuk Elgin
Aug 28, 2019·Journal of Glaucoma·Yiming YeMinbin Yu
Oct 21, 2016·Current Opinion in Ophthalmology·Chelvin C A SngKeith Barton
Sep 13, 2020·Clinical & Experimental Ophthalmology·Leonardo MastropasquaLuca Agnifili
Jun 20, 2019·Vestnik oftalmologii·N I Kurysheva
Jun 21, 2020·BMC Ophthalmology·Makoto GozawaMasaru Inatani
Aug 5, 2019·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Monika E DanielewskaMarek Rękas
Jan 7, 2017·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Chong-Da ChenLin Miao
Feb 16, 2018·Scientific Reports·Shuichiro AokiRyo Asaoka
Aug 28, 2020·Clinical Ophthalmology·Larae ZimprichJustin A Schweitzer
Oct 11, 2011·European Journal of Ophthalmology·Ivano RivaIrene Floriani